California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday.

Officials said then that they hoped California’s emergence as an insulin-maker would prompt prices to collapse. The new pens will be interchangeable with glargine, the generic alternative for more ...

(CNN) — Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...

Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom.Beginning Jan. 1, 2026, CalRx-branded ...

MONDAY, Oct. 20, 2025 (HealthDay News) — California will start selling low-cost insulin Jan. 1, nearly three years after ... CalRx — will be available at a recommended price of $11 per pen, or $55 for ...

The state of Oklahoma is suing drug companies who make insulin and the prescription benefit managers who help negotiate drug prices. Attorney General Gentner Drummond says the companies and benefit ...